4//SEC Filing
Levy Adam D. 4
Accession 0000905148-25-001075
CIK 0001781174other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:30 PM ET
Size
5.1 KB
Accession
0000905148-25-001075
Insider Transaction Report
Form 4
Levy Adam D.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-04-01+35,209→ 35,209 totalExercise: $1.68Exp: 2035-03-31→ Common Stock (35,209 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option vest on April 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.
Documents
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeother
Related Parties
1- filerCIK 0002061876
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 4:30 PM ET
- Size
- 5.1 KB